What an amazing #BCANTT24 it was! Thx Eugene Pietzak Stephanie Chisolm, PhD Rebecca Johnson, SC members, co-chairs, speakers, pt advocates & attendees for a fantastic meeting. It was all about patients from beginning to end! Looking forward to working w/ Max Kates for planning #BCANTT25

Put it in the Louvre

Only two weeks until the #IBCG24 Retreat! Looking forward to welcoming top bladder cancer experts, dedicated patient advocates and partners from around the globe to Houston The retreat chaired by Roger Li Patrick Hensley, MD Shilpa Gupta is all about collaboration: together, we’ll

#CORE-001 study: Promising results for #BladderCancer with cretostimogene grenadenorepvec and pembrolizumab. Trinity J. Bivalacqua Penn Medicine & Roger Li Moffitt Cancer Center join Ashish M. Kamat, MD, MBBS MD Anderson Cancer Center to discuss on UroToday > bit.ly/3XY8L2f CG Oncology, Inc.

.Roger Li, of Moffitt Cancer Center, details a post hoc analysis of patients with BCG-unresponsive non–muscle-invasive bladder cancer who did not respond to pembrolizumab. #blcsm onclive.com/view/dr-li-on-…

So sad to hear about the passing of Jeff Weber, a giant in the field of oncology. He was involved in the early days of cytokine and cell therapy and most recently led studies of personalized vaccines for melanoma patients. I originally worked with Jeff National Cancer Institute over 30 years ago.

Bladder-sparing treatment was found to be equally as effective at preventing disease recurrence as radical cystectomy in patients with high-risk, BCG–unresponsive NMIBC who showed nonresponse to pembrolizumab. Roger Li Moffitt Cancer Center #blcsm #oncology onclive.com/view/bladder-s…

Ashish M. Kamat, MD, MBBS #RogerBuckley kick off the IBCG 2nd in-person meeting. Extraordinary group of stakeholders (urology, medonc, reading, or advocates, basic scientists) in the room!

Shilpa Gupta Roger Li rocking the stage at #IBCG2024 IBCG

Fantastic start in IBCG 2nd in person meeting in Houston! Stellar participants & representation across many stakeholders! Ashish M. Kamat, MD, MBBS Roger Li Patrick Hensley, MD Sarah P. Psutka MD MS Jonathan Rosenberg MD Dr. Bishoy M. Faltas Shilpa Gupta Sia Daneshmand, M.D. Philippe spiess Andrea Necchi Karima Oualla, MD,MSc

The only & only Andrea Necchi taking the stage to discuss the progress in neoadjuvant tx in MIBC & the exciting developments IBCG #IBCG24 Ashish M. Kamat, MD, MBBS Roger Li Patrick Hensley, MD Petros Grivas Philippe spiess Carme Mir Gary Steinberg Jonathan Rosenberg MD

Excellent start of IBCG 2nd retreat in Houston! Rich multidisciplinary approach from different parts of the globe! Ashish M. Kamat, MD, MBBS Roger Li Patrick Hensley, MD Sarah P. Psutka MD MS Jonathan Rosenberg MD Petros Grivas Dr. Bishoy M. Faltas Shilpa Gupta Sia Daneshmand, M.D. Philippe spiess Andrea Necchi

Karima Oualla, MD,MSc discusses key Qs for Adjuvant Tx in MIBC w/Jonathan Rosenberg MD IBCG #IBCG24 A rapidly evolving space. Ashish M. Kamat, MD, MBBS Patrick Hensley, MD Roger Li Petros Grivas

🌟 Thrilled to join world experts at #IBCG24 IBCG in Houston 8/22-24 to develop key recommendations for bladder cancer! Honored to be invited as a moderator and team lead. Looking forward to advancing care together! 💪 🙏👍#OncologyLeadership UTMBUrology UTMB Health

We can’t wait to host this meeting in Tampa within the coming months! Global Society of Rare GU Tumors Roger Li Logan Zemp Ashish M. Kamat, MD, MBBS

Timely! Just out from #IBCG23 as we wrap up #IBCG24: Bladder-sparing Therapy for BCG–unresponsive NMIBC: International Bladder Cancer Group Recommendations for Optimal Sequencing and Patient Selection authors.elsevier.com/a/1jfA914kplyy… IBCG World Bladder Cancer Patient Coalition Bladder Cancer Advocacy Network

The way that Jensen Huang runs Nvidia is wild: 40 direct reports. No 1:1s. No formal planning cycles. And no status reports. In a recent interview, he went in-depth on his Leadership style. Every entrepreneur must understand why it works:

The very first thing I noticed is how hard Jensen works. He has been working 14 hours a day for decades. Very few have a strong enough mindset to even step into the ring with this man.

🚨About BCGu NMIBC: “In selected patients, initial BST offers comparable survival to RC. Rates of rec and prog increase over time, especially in patients treated with additional lines of BST” 📉BUT: comparable CSS 🔗 t.ly/sHk4G BJU International Ashish M. Kamat, MD, MBBS Roger Li

Alice Yu is a Urologic Oncologist at Moffitt Cancer Center in Tampa, Florida and has been an #AUAMember since 2013. Dr. Yu is one of the AUA faculty presenting at this week's AUA/SAU Lessons in Urology Course in Buenos Aires. Click for more ➡️ bit.ly/4e5D0ZO Sociedad Argentina de Urología🇦🇷